CASI Pharmaceuticals, Inc. Common Stock

$3.06 +$0.27 +8.82%

Own 2 of CASI at $3.79 which is 0.01% of the portfolio.

-$0.73 (-19.37%)

Shares Bought2
Shares Sold0
Shares Owned2
Last Price$3.06
Total Return-$1.47
Range Today$2.70 - $3.17
52 Week Range$0.91 - $4.84
Market Cap$184.20M
P/E Ratio-

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. The drugs are Captisol-Enabled, ZEVALIN and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.

Open Positions

Buy Date Buy Price Quote Return $ Return % Owners
12-05-17 21:04 $3.99 $3.06 -$0.93 -23.31% crizisaround
12-01-17 20:54 $3.60 $3.06 -$0.54 -15.00% crizisaround

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners